TDR Completed Its Investment in Buchang Group

On January 5 2011, TDR completed its investment in Buchang Group.

Buchang is China's leading cardiovascular and cerebrovascular pharmaceutical group. It is also the pharmaceutical group with most Chinese medicine patents and most patented herbal products in the world. The unique products, which are well protected by patents, bring it higher profitability than its counterparts. Also, its leading marketing networks in China help it build up strong platform value in China's pharmaceutical industry.